These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 37347510

  • 1. Brexpiprazole suppresses cell proliferation and de novo lipogenesis through AMPK/SREBP1 pathway in colorectal cancer.
    Li T, Liu X, Long X, Li Y, Xiang J, Lv Y, Zhao X, Shi S, Chen W.
    Environ Toxicol; 2023 Oct; 38(10):2352-2360. PubMed ID: 37347510
    [Abstract] [Full Text] [Related]

  • 2. α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades.
    Shi Y, Fan Y, Hu Y, Jing J, Wang C, Wu Y, Geng Q, Dong X, Li E, Dong D.
    J Cell Mol Med; 2020 Jan; 24(1):760-771. PubMed ID: 31762191
    [Abstract] [Full Text] [Related]

  • 3. Brexpiprazole Prevents the Malignant Progression of Human Colorectal Cancer Cells and Increases Its Sensitivity to EGFR Inhibition.
    Long X, Liu X, Xia W, Liu L, Chen W.
    Front Biosci (Landmark Ed); 2024 May 06; 29(5):174. PubMed ID: 38812296
    [Abstract] [Full Text] [Related]

  • 4. Suppression of Lipogenesis via Reactive Oxygen Species-AMPK Signaling for Treating Malignant and Proliferative Diseases.
    Fan XX, Leung EL, Xie Y, Liu ZQ, Zheng YF, Yao XJ, Lu LL, Wu JL, He JX, Yuan ZW, Fu J, Wei CL, Huang J, Xiao DK, Luo LX, Jiang ZB, Zhou YL, Kam RK, Liu L.
    Antioxid Redox Signal; 2018 Feb 10; 28(5):339-357. PubMed ID: 28665143
    [Abstract] [Full Text] [Related]

  • 5. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
    Long JK, Dai W, Zheng YW, Zhao SP.
    Mol Med; 2019 Jun 13; 25(1):26. PubMed ID: 31195981
    [Abstract] [Full Text] [Related]

  • 6. Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis.
    O'Brien AJ, Villani LA, Broadfield LA, Houde VP, Galic S, Blandino G, Kemp BE, Tsakiridis T, Muti P, Steinberg GR.
    Biochem J; 2015 Jul 15; 469(2):177-87. PubMed ID: 25940306
    [Abstract] [Full Text] [Related]

  • 7. SH2 domain-containing inositol 5-phosphatase (SHIP2) inhibition ameliorates high glucose-induced de-novo lipogenesis and VLDL production through regulating AMPK/mTOR/SREBP1 pathway and ROS production in HepG2 cells.
    Gorgani-Firuzjaee S, Meshkani R.
    Free Radic Biol Med; 2015 Dec 15; 89():679-89. PubMed ID: 26456051
    [Abstract] [Full Text] [Related]

  • 8. α-enolase promotes tumorigenesis and metastasis via regulating AMPK/mTOR pathway in colorectal cancer.
    Zhan P, Zhao S, Yan H, Yin C, Xiao Y, Wang Y, Ni R, Chen W, Wei G, Zhang P.
    Mol Carcinog; 2017 May 15; 56(5):1427-1437. PubMed ID: 27996156
    [Abstract] [Full Text] [Related]

  • 9. CAMKK2 Promotes Prostate Cancer Independently of AMPK via Increased Lipogenesis.
    Penfold L, Woods A, Muckett P, Nikitin AY, Kent TR, Zhang S, Graham R, Pollard A, Carling D.
    Cancer Res; 2018 Dec 15; 78(24):6747-6761. PubMed ID: 30242113
    [Abstract] [Full Text] [Related]

  • 10. Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway.
    Quan HY, Kim DY, Kim SJ, Jo HK, Kim GW, Chung SH.
    Biochem Pharmacol; 2013 May 01; 85(9):1330-40. PubMed ID: 23435355
    [Abstract] [Full Text] [Related]

  • 11. NR3C2 inhibits the proliferation of colorectal cancer via regulating glucose metabolism and phosphorylating AMPK.
    Liu H, Lei W, Li Z, Wang X, Zhou L.
    J Cell Mol Med; 2023 Apr 01; 27(8):1069-1082. PubMed ID: 36950803
    [Abstract] [Full Text] [Related]

  • 12. Novel SREBP1 inhibitor cinobufotalin suppresses proliferation of hepatocellular carcinoma by targeting lipogenesis.
    Meng H, Shen M, Li J, Zhang R, Li X, Zhao L, Huang G, Liu J.
    Eur J Pharmacol; 2021 Sep 05; 906():174280. PubMed ID: 34174265
    [Abstract] [Full Text] [Related]

  • 13. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.
    Wei X, Mao T, Li S, He J, Hou X, Li H, Zhan M, Yang X, Li R, Xiao J, Yuan S, Sun L.
    Phytomedicine; 2019 Feb 15; 54():120-131. PubMed ID: 30668361
    [Abstract] [Full Text] [Related]

  • 14. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK, Lung RW, Dawson CW, Young LS, Ko CW, Yeung WW, Kang W, To KF, Lo KW.
    J Pathol; 2018 Oct 15; 246(2):180-190. PubMed ID: 29968360
    [Abstract] [Full Text] [Related]

  • 15. A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis.
    Zadra G, Photopoulos C, Tyekucheva S, Heidari P, Weng QP, Fedele G, Liu H, Scaglia N, Priolo C, Sicinska E, Mahmood U, Signoretti S, Birnberg N, Loda M.
    EMBO Mol Med; 2014 Apr 15; 6(4):519-38. PubMed ID: 24497570
    [Abstract] [Full Text] [Related]

  • 16. Adenosine diphosphate-ribosylation factor-like 15 can regulate glycolysis and lipogenesis related genes in colon cancer.
    Du F, Zhang HJ, Shao W, Tu YY, Yang KJ, Piao LS.
    J Physiol Pharmacol; 2022 Jun 15; 73(3):. PubMed ID: 36302536
    [Abstract] [Full Text] [Related]

  • 17. Chronic treatment with the modified Longdan Xiegan Tang attenuates olanzapine-induced fatty liver in rats by regulating hepatic de novo lipogenesis and fatty acid beta-oxidation-associated gene expression mediated by SREBP-1c, PPAR-alpha and AMPK-alpha.
    Ren L, Sun D, Zhou X, Yang Y, Huang X, Li Y, Wang C, Li Y.
    J Ethnopharmacol; 2019 Mar 25; 232():176-187. PubMed ID: 30590197
    [Abstract] [Full Text] [Related]

  • 18. Curcumin Regulates the Progression of Colorectal Cancer via LncRNA NBR2/AMPK Pathway.
    Yu H, Xie Y, Zhou Z, Wu Z, Dai X, Xu B.
    Technol Cancer Res Treat; 2019 Mar 25; 18():1533033819870781. PubMed ID: 31888414
    [Abstract] [Full Text] [Related]

  • 19. Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis.
    Li W, Tai Y, Zhou J, Gu W, Bai Z, Zhou T, Zhong Z, McCue PA, Sang N, Ji JY, Kong B, Jiang J, Wang C.
    Cell Cycle; 2012 Jun 15; 11(12):2348-58. PubMed ID: 22672904
    [Abstract] [Full Text] [Related]

  • 20. Ginkgolic acid suppresses the development of pancreatic cancer by inhibiting pathways driving lipogenesis.
    Ma J, Duan W, Han S, Lei J, Xu Q, Chen X, Jiang Z, Nan L, Li J, Chen K, Han L, Wang Z, Li X, Wu E, Huo X.
    Oncotarget; 2015 Aug 28; 6(25):20993-1003. PubMed ID: 25895130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.